Back

Torrential tricuspid regurgitation and outcomes after transcatheter tricuspid edge-to-edge repair: Insights from the EuroTR registry

31 August 2026 (11:05 - 11:15)
Organised by: Logo
Congress Presentation Part of: Transcatheter tricuspid therapies: clinical results and future directions Tricuspid Valve Intervention ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Lara Waldschmidt

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

5 More presentations in this session

Presentation thumbnail
Acute impact on right ventricular function following orthotopic transcatheter tricuspid valve replacement. Insights from deformation imaging and non-invasive pressure–volume analysis
Doctor C. Herrera (Salamanca, ES)
Abstract Slides Video
Presentation thumbnail
The TRICURE FIH study results and future trials update
Professor J. Hausleiter (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Right atrial–right ventricular coupling drives decongestion and residual regurgitation after transcatheter tricuspid repair
Doctor P. Craciun (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of renal function improvement following tricuspid transcatheter edge-to-edge repair: Insights from the EuroTR Registry
Doctor S. Ludwig (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Baseline New York Heart Association class as a prognostic marker and determinant of symptomatic response after tricuspid valve transcatheter edge-to-edge repair: insights from the EuroTR registry
Doctor C. Wolff (Leipzig, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Transcatheter tricuspid therapies: clinical results and future directions
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 11:05 CET
You may be interested in
thumbnail
Congress Presentation
Impact of tricuspid valve morphology on outcomes after transcatheter edge-to-edge repair: insights from the euroTR registry
31 August 2026
thumbnail
Congress Presentation
How Much Tricuspid Regurgitation Reduction Is Enough? Residual TR and Long-Term Outcomes After T-TEER in the Randomized TRI-FR Extension
31 August 2026
thumbnail
Congress Presentation
TRISCEND II trial: TTVR outcomes by baseline TR severity
29 August 2025
thumbnail
Congress Presentation
Treating severe tricuspid regurgitation
11 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources